Back to Rankings

PACS

PACS GroupA
NYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
25%
Probability
Target price
$46.40
+0.6% vs current
Most likely
B
Base case
50%
Probability
Target price
$40.00
-13.3% vs current
B-
Bear case
25%
Probability
Target price
$28.00
-39.3% vs current

AI sentiment snapshot

Latest data as of 2026-06-11
Recent news sentiment (30D)
+30.0
Positive
Company
-
Unavailable
Macro
+30.0
Positive
Pulse
-
Unavailable
Sentiment proxy
+30.0
Score

AI commentary

Primary-source evidence is strong and the May 11, 2026 earnings release was clearly constructive, but the current setup still looks like a monitoring-style long rather than a full rerate. News flow is concentrated around the Q1 print, social coverage is not provided, and the packet does not include post-print analyst revision data, so improving fundamentals are only partly validated by external follow-through.

RankAlpha Sentiment Codex - 2026-06-11
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-05-11eventQ1 results supported a higher 2026 EBITDA outlook and a new buybackHigh impact

PACS reported Q1 2026 revenue of $1.42 billion, net income of $80.7 million, and adjusted EBITDA of $170.4 million, then raised full-year adjusted EBITDA guidance to $605 million-$625 million, reaffirmed revenue guidance of $5.65 billion-$5.75 billion, and disclosed a $250 million share repurchase authorization effective May 7, 2026. [#SEC-8K-2026-05-11]

2026-08-01catalystPart of the Q1 upside came from a timing-sensitive WQIP benefitMedium impact

Q1 adjusted EBITDA included about $16.3 million of net benefit from California WQIP payments that were not in prior guidance because amount and timing were uncertain, so some of the quarter's margin upside is not a clean recurring run-rate. [#SEC-8K-2026-05-11]

2026-12-31catalystOccupancy, skilled-mix gains, quality scores, and liquidity support multi-quarter compoundingMedium impact

Same-store SNF revenue rose 8.0%, occupancy improved to 90.9%, overall skilled mix reached 30.5%, 78.4% of the skilled nursing portfolio held 4- or 5-star CMS Quality Measure ratings, operating cash flow was $236.3 million, and available liquidity was $795.1 million, supporting continued operating execution and capital deployment. [#SEC-8K-2026-05-11]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology